Published on
September 29, 2026
- 13:00 GMT
MAPLE trial endpoint: PhenoBiome prebiotic raises gut microbial diversity, measured on Perseus Biomics’ DynaMAP platform
Clinical trial shows significant gain in gut diversity alongside improved quality-of-life scores; DynaMAP validated against sequencing for microbiome read-outs. PALM SPRINGS, CA, UNITED STATES, September 29, 2026 /EINPresswire.com/ -- PhenoBiome today …
Distribution channels:
Beauty & Hair Care, Food & Beverage Industry
...
